ICU Medical (NASDAQ:ICUI) Downgraded by StockNews.com to “Hold”

ICU Medical (NASDAQ:ICUI) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Thursday.

Other equities analysts have also issued research reports about the stock. KeyCorp decreased their price target on shares of ICU Medical from $209.00 to $191.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Raymond James set a $97.00 target price on ICU Medical in a report on Wednesday, March 12th. Finally, Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $162.67.

ICU Medical Trading Down 1.1 %

Shares of ICUI stock opened at $135.66 on Thursday. The firm’s 50-day simple moving average is $143.81 and its 200-day simple moving average is $158.23. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical has a 1-year low of $94.19 and a 1-year high of $196.26. The firm has a market cap of $3.33 billion, a P/E ratio of -29.68 and a beta of 0.86.

Hedge Funds Weigh In On ICU Medical

Hedge funds have recently made changes to their positions in the business. Kirr Marbach & Co. LLC IN boosted its position in ICU Medical by 63.6% during the 1st quarter. Kirr Marbach & Co. LLC IN now owns 35,870 shares of the medical instruments supplier’s stock worth $4,981,000 after purchasing an additional 13,951 shares during the period. Blue Trust Inc. boosted its position in shares of ICU Medical by 23.0% in the first quarter. Blue Trust Inc. now owns 801 shares of the medical instruments supplier’s stock worth $111,000 after buying an additional 150 shares during the period. SG Americas Securities LLC purchased a new stake in shares of ICU Medical in the first quarter worth about $859,000. GAMMA Investing LLC raised its holdings in shares of ICU Medical by 27.2% during the 1st quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier’s stock valued at $99,000 after buying an additional 153 shares during the period. Finally, Vise Technologies Inc. lifted its position in ICU Medical by 7.1% during the 4th quarter. Vise Technologies Inc. now owns 2,649 shares of the medical instruments supplier’s stock worth $411,000 after acquiring an additional 176 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.